This month the reflection brought by Blue November refers to male health. In the fight against prostate cancer, the campaign warns of the prevention and early diagnosis of the disease. "Active tumor detection and discovery before progression reduces the mortality rate for this disease," says urologist at the University Hospital Nazareno Pereira Fernandes, and refers to a Swedish study that suggests a 44% mortality reduction in these patients.
According to a doctor, in men who have the first degree of prostate cancer and people of African origin, they are more likely to develop the disease. Age is another risk factor, so Fernandes points out the need for a 45-year-old exam, in those with family history or black for 40 years. "This has greatly reduced resistance and required a rectal examination. The tendency is to avoid probing, but 30% of the tumor does not produce PSA, a substance identified by blood," explains the doctor.
In the month of male-oriented programming, the urologist emphasizes that intent is not to intimidate people but to promote disease prevention. "Blue November is a happy call, so a man will look after his health."
Last year, 44 patients were hospitalized in hospital hospitals, prostate cancer victims. From the form of prevention, the secretariat points out the training of medical teams of Basic Health Units (BHU), human health and prevention lectures.
In the D-Day of Blue November, the municipality will offer medical and dental care, along with men's exams, in an extended shift. It will be November 24 in all UBS.
In the initial phase, when the outlook for treatment is 90%, there are no symptoms. The absence of symptoms does not guarantee that there is no problem.
In advanced stage:
– bone pain;
– pain in the urination;
– require frequent urination;
– presence of blood in urine and / or seeds.
Diagnosis and treatment
The only way to secure a drug for prostate cancer is early diagnosis. Even in the absence of symptoms, men over the age of 40 with risk factors, or 45 years without these factors, should go to urologist to discuss rectal examination that allows the physician to assess changes in the glands, such as hardening and presence of suspect nodules, and on the blood PSA (prostate specific antigen). Approximately 30% of patients with prostate cancer only diagnose rectal rectal examination. The type of treatment will depend on the degree of disease in each patient.